SCHEMBL21324366

SCHEMBL21324366

CC(C)n1c2ccccc2c2cc3c(cc21)N(c1ccc2cc(N4c5ccccc5Oc5cc6c7ccccc7n(C(C)C)c6cc54)ccc2c1)c1ccccc1O3

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ NPY5R Q15761 4/20 0.36
▸ BCHE P06276 1/20 0.36
▸ ACHE P22303 1/20 0.36
▸ MAPT P10636 2/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ CASP7 P55210 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ RORC P51449 1/20 0.31
▸ P2RX4 Q99571 1/20 0.31
▸ CYP1A2 P05177 1/20 0.30
▸ POLB P06746 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21514265 1.00 MEN1 (0.40) MEN1KMT2ANPY5RBCHEACHE
SCHEMBL16696175 0.89 MEN1 (0.46) MEN1KMT2ANPY5RBCHEACHE
SCHEMBL16696176 0.85 MEN1 (0.40) MEN1KMT2ANPY5RBCHEACHE
SCHEMBL21324350 0.79 MEN1 (0.39) MEN1KMT2ANPY5RBCHEACHE
SCHEMBL21324515 0.78 CDK8 (0.34) MAPTSMN1; SMN2NPSR1ATM
SCHEMBL21514755 0.78 CDK8 (0.34) MAPTSMN1; SMN2NPSR1ATM
SCHEMBL21324284 0.77 MEN1 (0.38) MEN1KMT2ANPY5RBCHEACHE
SCHEMBL21514394 0.77 MEN1 (0.38) MEN1KMT2ANPY5RBCHEACHE
SCHEMBL18056702 0.75 GPR3 (0.47) MEN1KMT2ANPY5RBCHEACHE
SCHEMBL21514257 0.75 KDM4E (0.33) ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190273210-A1 HETEROAROMATIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2019-09-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190273210-A1 HETEROAROMATIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME VDAC1, TRPC6, TRPC5 MEN1 1722/4885KMT2A 1998/4885NPY5R 4153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback